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Abstract
To assess inflammatory bowel disease (IBD) patients’ experience of chronic illness care and the relationship with demographic and
healthcare-related characteristics.
This cross-sectional survey used the Instrument to Evaluate the EXperience of PAtients with Chronic diseases (IEXPAC)
questionnaire to identify parameters associated with a better healthcare experience for IBD patients. IEXPAC questionnaire
responses are grouped into 3 factors - productive interactions, new relational model, and patient self-management, scoring from 0
(worst) to 10 (best experience). Scores were analyzed by bivariate comparisons and multiple linear regression models.
Surveys were returned by 341 of 575 patients (59.3%, mean age 46.8 (12.9) years, 48.2%women). Mean (SD) IEXPAC score was
5.9 (2.0); scores were higher for the productive interactions (7.7) and patient self-management factors (6.7) and much lower for the
new relational model factor (2.2). Follow-up by a nurse, being seen by the same physician, and being treated with a lower number of
medicines were associated with higher (better) overall patient experience score, and higher productive interactions and self-
management factor scores. A higher productive interactions score was also associated with patients receiving medication
subcutaneously or intravenously. Higher new relational model scores were associated with follow-up by a nurse, affiliation to a
patients’ association, receiving help from others for healthcare, a lower number of medicines and a higher educational level.
In patients with IBD, a better overall patient experience was associated with follow-up by a nurse, being seen by the same
physician, and being treated with a lower number of medicines.
Abbreviations: ACCU = Spanish Association of Patients with Crohn Disease and Ulcerative Colitis, CD = Crohn Disease,
CONARTRITIS = Spanish Association of Patients with Arthritis, FEDE = Spanish Federation of Patients with Diabetes, HRQoL =
Health-Related Quality of Life, IBD = inflammatory bowel disease, IEXPAC = Instrument to Evaluate the EXperience of PAtients with
Chronic diseases, IV = intravenous, N-ECCO = Nurses European Crohn and Colitis Organisation, PACIC = Patient Assessment of
Chronic Illness Care, PPIC = Patient Perceptions of Integrated Care, SC = subcutaneous, SD = standard deviation, SEISIDA =
Spanish AIDS Multidisciplinary Society, UC = ulcerative colitis.
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1. Introduction
Patient experience with healthcare is positively associated with
clinical effectiveness and patient safety in a wide range of diseases
and care settings such as hospitalization and primary care
visits.[1] In chronic disease, the delivery of high-quality care
significantly improves patients’ experience,[2] with productive
patient–professional interactions being critical for patient well-
being and the quality of care.[3] Multidisciplinary care teams,
which often include nurses and pharmacists, are also required for
effective chronic illness management.[4]
Inflammatory bowel disease (IBD) is a chronic condition
characterized by chronic inflammation of the gastrointestinal tract
and is categorized into ulcerative colitis (UC) and Crohn Disease
(CD). IBD adversely affects health-related quality of life
(HRQoL),[5–7] and can have a major impact on the activities of
daily living.[8–11] For healthcare, IBD patients require a collabora-
tive, multidisciplinary approach.[12,13] Increased specialized care
involving a gastroenterologist, a nurse with experience in the care of
IBD patients and other specialists is associated with improved
outcomes in IBD.[14–16]However, there is relatively little information
regarding patients’ experience with healthcare and perceived needs
in IBD and how this relates to specialized healthcare.
Instruments to assess the experience of chronic patients include
the 20-item Patient Assessment of Chronic Illness Care
(PACIC),[17] the Patient Perceptions of Integrated Care (PPIC)
survey,[18,19] and the Instrument to Evaluate the Experience of
Patients with Chronic Diseases (IEXPAC).[20] The main
advantages of the IEXPAC scale are that it accounts for the
interaction of patients with healthcare teams, instead of focusing
on specific professionals; incorporates a broader notion of
integrated care, including social care and patient self-manage-
ment; and includes new technological interventions and patients’
interactions with other patients.[20]
We previously reported the outcomes of a survey to assess the
experience of patients with 4 different chronic conditions:
diabetes mellitus, HIV infection, rheumatic disease, or IBD, with
healthcare using the IEXPAC questionnaire.[21] In the current
work, we focus on the group of patients with IBD, with the
objective of assessing their experience with healthcare using the
IEXPAC scale, identifying areas of improvement in healthcare
and to explore the potential influence of demographic and
healthcare-related variables on patients’ experiences.
2. Methods
This was a cross-sectional survey of adult patients (aged >18
years) with IBD who were attending hospital clinics in Spain
which assessed patients’ experience of chronic illness care. This
patient cohort was part of a larger study of 4 chronic diseases:
diabetes mellitus, HIV infection, rheumatic disease and IBD.[21]
A total of 23 gastroenterology units from hospital clinics
participated in the study. The survey was handed to the first 25
consecutive patients attending their gastroenterology clinic
routinely, regardless of age, gender, disease severity or any
other criterion. The survey was conducted between May and
September 2017 and was distributed to patients by their treating
physician or nurse. The survey was reviewed and approved by
the Clinical Investigation Ethics Committee of the Gregorio
Marañón Hospital, Madrid, Spain.
Patients were instructed to read the survey and complete it
voluntarily and anonymously from home, and to return it by pre-
paid mail. Survey documentation included information for
patients regarding the anonymous nature of the survey and
aggregated data processing, thus ensuring that patient identifica-
tion was not possible. As accepted by the Clinical Investigation
Ethics Committee, the return of completed questionnaires was
taken as implied consent to participate in the study. There was no
collection of clinical data in this study.
The study protocol, methodology and main outcomes for the
overall population have been described elsewhere.[21] Taking the
IEXPAC 2015 scale as the starting point, the content of the overall
survey was developed for this study with the participation of 4
expert physicians in the treatmentof the above-mentionedpatients,
and was reviewed by members of 3 patients’ associations: the
Spanish Association of Patients with Arthritis (CONARTRITIS),
the Spanish Association of Patients with Crohn Disease and
Ulcerative Colitis (ACCU), and the Spanish Federation of Patients
with Diabetes (FEDE), and by members of the Spanish AIDS
Multidisciplinary Society (SEISIDA), a Spanish Society composed
of patients with HIV infection and different healthcare profes-
sionals. Patients reviewed the content and appropriateness of the
questions and language used, and suggested modifications or
additional questions. Except for validatedquestionnaires including
IEXPAC,whichwere notmodified, suggestions frompatientswere
included in the final survey. The study was endorsed by the above-
mentioned patients’ associations.
2.1. Survey instrument
The survey included multiple-choice questions that provided
information on patients’ demographics, healthcare-related char-
acteristics, follow-up by different specialists or nurses, and
treatment characteristics (Supplementary Material, http://links.
lww.com/MD/C900). The IEXPAC questionnaire was a specific
part of the survey. The first version of the IEXPAC (2015 version
11+1) was used in this study.
The IEXPAC questionnaire was developed in 2015 through a
thorough process of literature review, with input from an expert
panel (including healthcare professionals and social organiza-
tions, and experts in quality of healthcare and chronic diseases).
Its content, validity and reliability were assessed following pilot
and field work involving 356 chronically ill patients.[20]
The questionnaire was designed to be self-administered by
patients and consists of 11 items, plus 1 additional item for
patients whowere hospitalized recently. The items refer to the last
6 months, except the question on hospitalization, which refers to
the last 3 years. A description of each item (as presented to
patients) is displayed in Table 1. For each item, patients
responded using a 5-point Likert scale, that was subsequently
transformed using a fixed scoring system: “always” (score 10),
“mostly” (score 7.5), “sometimes” (score 5), “seldom” (score
2.5) and “never” (score 0). The scale yields an overall score (sum
of individual scores of the 11 items divided by 11) between 0
(worst experience) and 10 (best experience) and allows
identification of items in which improvement is needed.
Three factors are derived from the first 11 IEXPAC items.
Factor 1 is named “productive interactions” and refers to the
characteristics and content of interactions between patients and
professionals oriented to improve outcomes. The productive
interactions score is the average of the scores from items 1, 2, 5,
and 9. Factor 2, the “new relational model”, refers to new forms
of patient interaction with the healthcare system, through the
internet or with peers. Its score is the average of the scores of items
3, 7, and 11. Finally, Factor 3, named “patient self-manage-
ment”, refers to the ability of individuals to manage their own
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care and improve their wellbeing based on healthcare profes-
sional-mediated interventions. The patient self-management
score is the average of the scores from items 4, 6, 8, and 10.
The 12th item refers to continuity after hospitalization and is
described separately.
2.2. Statistical analysis
By its nature, this survey is exploratory, and no formal hypothesis
or pre-specified sample size was calculated. Taking a conservative
approach, we estimated a sample size of 267 patients based on a
qualitative variable with 50% as the expected prevalence, a
confidence interval of 95% and 6% precision. Assuming that the
variables would not be completed correctly by 15% of patients,
the total size of the sample to recruit was estimated to be 314
patients. To this number, we added the expected response rate to
calculate the final number of surveys. Assuming a 50% response
rate, as seen in other surveys,[22,23] we determined that we would
need a survey sample size of approximately 628 patients with
each background disease.
Descriptive information is displayed as mean and standard
deviation (SD) for quantitative variables and frequencies or
percentages for qualitative variables. The results of the IEXPAC
questionnaire were calculated as overall mean (SD) score and
mean (SD) scores of the 3 above-mentioned factors. The
distribution of responses to the individual items is also displayed,
as well as the sum of the percentages of “always” plus “mostly”
responses to each item.
Chi-squared or Fisher exact tests were used for the comparison
of proportions and the Student t or the ANOVA test to compare
continuous variables. Multiple linear regression models were
used to assess the different demographic and healthcare-related
variables influencing the IEXPAC overall score and the score for
each factor. Beta coefficients with P values are shown. Given the
overall descriptive nature of the results, no multiplicity adjust-
ments were made. There was no imputation for missing data.
3. Results
3.1. Description of the sample
The survey was handed to 575 patients with IBD and 341 were
returned (response rate: 59.3%). The mean (SD) age of
respondents was 46.8 (12.9) years and consisted of approxi-
mately equal numbers of men (51.8%) and women (48.2%). The
educational level achieved was 30.2% for primary studies,
Table 1
Word-for-word IEXPAC items. Percentage of patients who responded “mostly” or “always” to each item and mean score (standard
deviation).
IEXPAC item
Percentage (%)
who responded
“mostly” or “always”
Mean (SD)
score
1. They respect my lifestyle
The professionals who care for me listen to me and ask me about my needs, habits and preferences to adapt my
treatment and care plan
75.1 8.0 (2.6)
2. They are coordinated to offer me good health care
Health and social care services are coordinated to improve my wellbeing and quality of life in my environment (family,
neighbourhood, town).
61.9 6.6 (3.5)
3. They help me to get information from the internet
The professionals who care for me inform me about trusted webpages and internet forums that I can consult to better
know my disease, its treatment and the consequences they may have on my life.
19.0 2.9 (3.5)
4. Now I can take care of myself better
I feel that confidence in my ability to take care of myself, manage my health problems and keep my autonomy has
improved.
79.3 7.8 (2.4)
5. They ask me and help me to follow my treatment plan
I regularly review the adherence to my treatment and care plan with the professionals who care for me.
77.8 8.2 (2.6)
6. We set goals for a healthy life and better control of my illness
I have been able to agree with the professionals who care for me on specific objectives regarding diet, physical exercise
and medication to get better control of my health problems.
62.6 6.8 (3.4)
7. I can use the internet and my mobile phone to consult my medical records
I can consult my clinical record, tests results, programmed visits and access to other services through the internet or a
mobile app of my health service.
5.5 1.1 (2.5)
8. They make sure that I take medication correctly
The professionals who care for me review with me all of the medication I take, how I take it and how it suits me.
73.7 7.7 (3.3)
9. They worry about my welfare
The professionals who care for me are concerned with my quality of life and I feel they are committed to my wellbeing
80.4 8.4 (2.6)
10. I have been informed on the health and social resources that can help me
The professionals who care for me inform me about the health and social resources available in my neighbourhood or
town that I can use to improve my health problems and take better care of myself.
32.3 4.4 (3.7)
11. They encourage me to talk to other patients
The professionals who care for me invite me to participate in patient groups to share information and experiences on how
to care for ourselves and improve our health.
15.7 2.8 (3.4)
Respond to the following statement only if you have been admitted to the hospital in the last 3 years,
12. They care about me when I come home after being in hospital
After hospital discharge, they have called or visited me at home to see how I was and what care I needed.
28.9 3.3 (4.2)
“Productive Interactions” factor: items 1, 2, 5 and 9; “New Relational Model” factor: items 3, 7 and 11; “Patient Self-Management” factor: items 4, 6, 8, and 10.
IEXPAC = Instrument to Evaluate the EXperience of PAtients with Chronic diseases.
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42.1% for secondary studies including vocational studies, and
27.8% for university or higher. Some 10.1% of patients declared
an affiliation with a patients’ association. For their follow-up,
7.8% needed to travel to a Spanish region different from their
home region. Nearly three-quarters of patients (73.4%) searched
for information about disease characteristics, medication, diet or
lifestyle using alternative sources to those provided by healthcare
professionals. The most frequently reported sources were web
pages specialized in health (56.9%), general web pages (21.7%),
general media (18.8%), patients’ societies (19.1%) and other
patients (27.9%).
With regard tohealthcare-related characteristics, patients visited
amean (SD) of 3.8 (2.1) specialists (including primary care) during
the previous year. The specialists most frequently visited by IBD
patients were primary care physicians (85.3%), rheumatologists
(23.8%), gynecologists (22.9%), dermatologists (19.9%) and
orthopedic surgeons (17.6%). For their treating physician, 85.2%
of patients declared that theywere usually followed up by the same
physician (i.e., the same gastroenterologist), 10.6% reported that
the physician was sometimes different and 4.2% declared that the
physician was frequently different. Regular follow-up by a nurse
was reported by 44.3% of patients. For their healthcare, 59.2%
declared taking care of themselves, whilst 40.8% received help
from others, that is, relatives, friends or caregivers.
Regarding their treatment, patients received a mean (SD)
number of 3.5 (2.4) different medications, with 42.2% receiving
subcutaneous (SC) or intravenous (IV) medication. During the
past 3 years, 50.7% of patients had been hospitalized (for any
reason) at least once.
3.2. IEXPAC responses and experience scores
Figure 1 displays the distribution of responses to the 12 IEXPAC
items and their mean scores. Table 1 shows the word-for-word
items, the proportion who responded “always” or “mostly” to
each item and the mean (SD) scores for each item. For the items
related to productive interactions (Factor 1) and patient self-
management (Factor 3), the proportion of patients who
responded “always” or “mostly” was >60% except for one
Factor 3 item (“I have been informed on the health and social
resources that can help me”). In contrast, the proportion and
scores of items relating to new relational model (Factor 2) were
low (<20% responded “always” or “mostly”). Of 173 patients
who had been hospitalized in the past 3 years, only 50 (28.9%)
responded “always” or “mostly” to item 12 (“They care about
me when I come home after being in hospital”), whilst 110
(63.6%) reported this “seldom” or “never” happened.
The mean (SD) IEXPAC score was 5.9 (2.0) overall. Scores
were higher for the productive interactions and patient self-
management factors and much lower for the new relational
model factor (Table 2). The overall IEXPAC experience score and
the scores for the 3 different factors were significantly higher
(indicating a better experience) in patients who were followed-up
by a nurse or seen by the same physician (except the new
relational model factor); and lower (a worse experience) in those
taking a higher number of medicines, especially in patients being
treated with 5 or more different drugs (Table 2).
Scores did not differ between men and women or between
age quartiles, except for the new relational model, that was
higher in younger patients (P linear trend= .039). Patients
with a higher educational level and those affiliated with
patients’ associations scored higher in the new relational
model factor, and patients treated with SC or IV medication
had higher productive interactions scores. The specific scores
stratified by different variables are displayed in Table 2 and in
Supplementary Tables, http://links.lww.com/MD/C900. A sum-
mary of bivariate comparisons with statistical significance is
provided in Table 3.
23
12
20
64
59
5
41
59
41
12
36
53
6
4
12
17
15
1
21
19
38
7
26
22
7
17
22
12
11
5
15
15
15
16
17
17
9
18
16
5
6
11
14
4
3
14
7
6
55
49
30
2
9
78
9
3
2
51
14
2
12. They care about me when I come home after being in hospital
11.They encourage me to talk to other patients
10. I have been informed on the health and social resources that
can help me
9. They worry about my welfare
8. They make sure that I take medication correctly
7. I can use the Internet and my mobile phone to consult my
medical records
6. We set goals for a healthy life and better control of my illness
5. They ask me and help me to follow my treatment plan
4. Now I can take care of myself better
3. They help me to get information from the Internet
2. They are coordinated to offer me good health care
1.They respect my lifestyle
Always Mostly Sometimes Seldom Never
Figure 1. Frequency distribution of patients’ responses to IEXPAC items. Numbers in bars represent the percentage who responded to each option.
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3.3. Multivariate analysis
Table 4 shows the results of the multiple linear regression models.
Having follow-up by a nurse, being seen by the same physician
and treatment with a lower number of medicines, were associated
with a better overall experience score, and better productive
interactions and self-management factor scores. Treatment with
SC or IV medications was associated with a better productive
interactions factor score. Finally, follow-up by a nurse, affiliation
with a patients’ association, receiving help from others for
healthcare, a lower number of medicines and a higher educational
level, were associated with a better new relational model factor
score (Table 4). The models explained only a small part of the
variability (goodness of fit (R2) for the overall IEXPAC score:
0.119, Table 4).
4. Discussion
This observational study, which primarily used the IEXPAC
questionnaire,[20] identified a series of parameters that were
associated with a better experience for IBD patients receiving care
in outpatient hospital clinics. A better overall patient experience
was associated with follow-up by a nurse, being seen by the same
physician, and being treated with a lower number of medicines.
These parameters were also associated with higher productive
interactions and self-management factor scores. Patients treated
with SC or IV medication also had better productive interactions
scores. Higher new relational model scores were associated with
follow-up by a nurse, affiliation to a patients’ association,
receiving help from others for healthcare, a lower number of
medicines and a higher educational level. Moreover, patients’
responses to IEXPAC statements identified areas for improve-
ment in healthcare, especially those associated with access to
reliable information and services, interaction with other patients
and continuity of healthcare after hospital discharge.
The survey was based on 341 responding IBD patients with a
mean age of 46.8 years from hospital clinics. This cohort is likely
to consist of patients with established IBD as the peak incidence
of both UC and CD occurs in the 15 to 29-year age group.[24] The
Table 2
IEXPAC experience scores. Overall score and score of the different healthcare-related factors.
Overall IEXPAC
experience
score
Productive Interactions
score
(Factor 1)
New Relational
Model score
(Factor 2)
Patient
Self-management
score (Factor 3)
Overall population 5.9 (2.0) 7.7 (2.3) 2.2 (2.2) 6.7 (2.4)
Follow-up by a nurse
Yes (n=110) 6.4 (2.1) 8.3 (2.1) 2.8 (2.7) 7.2 (2.4)
No (n=181) 5.6 (2.1) 7.4 (2.3) 1.9 (1.9) 6.4 (2.3)
P value <.001 .002 .001 .005
Follow-up by the same physicians
Usually the same physician (n=250) 6.0 (1.9) 7.9 (2.2) 2.3 (2.3) 6.8 (2.3)
Sometimes/frequently different (n=43) 5.0 (2.1) 6.6 (2.5) 1.9 (2.2) 5.0 (2.6)
P value .002 <.001 .220 .008
Number of different medicines taken
0 to 2 (n=113) 6.1 (2.1) 8.0 (2.4) 2.4 (2.5) 6.8 (2.4)
3 or 4 (n=98) 6.0 (1.8) 7.8 (2.2) 2.5 (2.1) 6.9 (2.2)
5 or more (n=69) 5.3 (1.8) 7.1 (2.2) 1.5 (1.8) 6.2 (2.4)
P trend .010 .012 .014 .144
Values are mean (SD).
IEXPAC = Instrument to Evaluate the EXperience of PAtients with Chronic diseases.
Table 3
Bivariate analysis. Variables associated with better experience scores. See Supplementary Tables, http://links.lww.com/MD/C900 for
additional information.
Overall IEXPAC
experience
score
Productive
Interactions
score (Factor 1)
New Relational
Model score
(Factor 2)
Patient
Self-management
score (Factor 3)
Age – – Lower age
∗
–
Gender – – – –
Educational level achieved – – Higher
∗
–
Affiliated to patients’ association – Not affiliated Affiliated –
Follow-up in a region different from home region (vs same region) – – – –
Number of specialists visited in the past year Lower +
∗
– – –
Being followed by the same physician (vs different) Same physician Same physician – Same physician
Being followed by a nurse (vs no nurse follow-up) Follow-up by nurse Follow-up by nurse Follow-up by nurse Follow-up by nurse
Having help from others for health care (vs only self-care) – – – –
Number of different medicines taken Lower
∗
Lower
∗
Lower
∗
–
Being treated with SC/IV drugs (vs no SC/IV treatment) – Treatment with SC/IV drugs + – –
The table displays the values of the variables associated with better experience scores in the bivariate analysis (P< .05, except +P= .050).
IEXPAC= Instrument to Evaluate the EXperience of PAtients with Chronic diseases, IV= intravenous, SC= subcutaneous.
∗
denotes a linear trend.
Marín-Jiménez et al. Medicine (2019) 98:14 www.md-journal.com
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response rate of 59.3% was comparable to those reported for
surveys of other chronic diseases, which varied from 53% to
59.2%.[22,23]
The associations found in this study between better IEXPAC
scores and several healthcare-related variables are important to
drive efforts from a healthcare planning perspective. Firstly, the
important role of nurses in the care of IBD patients is emphasized.
Consensus statements issued recently by the Nurses European
Crohn and Colitis Organisation (N-ECCO) for the care of IBD
patients describe the critical and varied roles of nurses in the care
of these patients.[25] The effectiveness of an IBD specialist nurse in
the management of IBD patients has been described previously
and included a reduction in hospital visits and improvement of
patients’ satisfaction and information on IBD.[26,27] Moreover,
from the patient’s perspective, an interview-based survey in Spain
of CD patients emphasized the requirement for a dedicated
healthcare professional, such as a specialist nurse, to attend to the
daily needs of newly-diagnosed patients who are ill-equipped to
deal with the uncertainty of the disease course.[28] Thus, our
study contributes to reinforce the importance of the nurse’s role.
Second, our survey results also suggest the importance of
reducing the number of physicians following the patient and that
the same specialists follow the patient over time. Emotional links
between patient and physician and a trusting relationship are of
special importance in improving outcomes in patients with
chronic disases.[29–31] Finally, our findings indicate that simplifi-
cation of treatment regimens, taking a lower number of
medicines, can lead to a better experience for patients. We
found that patients treated with SC or IV medication had better
productive interactions scores, which may be conditioned by
closer and more personalized follow-up of these patients. In
Spain, patients needing SC or IV drugs are usually followed-up by
specialized IBD teams (physicians, nurses and even psychologists)
with dedicated space in the clinic, which allows a higher number
of quality interactions between patients and healthcare profes-
sionals.
The responses of patients to the IEXPAC statements also
indicate areas of improvement in healthcare. Low proportions of
patients responded “always” or “mostly” to Factor 2 statements
(new relational model), and Factor 2 scored much lower than
Factors 1 and 3. However, there was an association between
“receiving help from others for healthcare” and better new
relational model scores. In chronic diseases, such as IBD, with a
high personal burden, support from others for healthcare –
involving patients’ relatives or other patients – can have a positive
impact on how patients confront everyday life and care.
However, only 10.1% of patients were affiliated with a patients’
association, although the benefits of affiliation were also shown
through higher new relational model scores. This may be due to a
lack of encouragement by health professionals, as only 15.7% of
patients reported that they were regularly encouraged to
participate in patients’ groups. Only about one-fifth of patients
(19%) reported that they were guided by health professionals to
access information from the internet from trusted sites. However,
most patients (73.4%) declared using alternative sources for
information about IBD. Information accessed from general web
pages or the general media which were accessed by 22% and
19% of patients respectively, may be unsuitable for providing
patients with relevant information. Consequently, increased
efforts should be made by healthcare professionals to direct
patients to trusted sources of information, such as webpages of
patients’ associations or scientific societies which contain content
and language that has been adapted for use by non-healthcare
professionals.
Patients’ responses also describe that, although 50% of
patients were hospitalized during the previous 3 years, only
30% of patients declared that they had received a call or a home
visit after discharge. This is an area for improvement, as patients
with IBD commonly have complications needing hospitalization
and these patients require continuous, specialized and personal-
ized care. Because the IBD cohort was recruited in outpatient
hospital clinics, the sample probably included patients with
difficult-to-treat disease (represented by the fact that 42% of
patients were receiving SC or IV medication, likely biological
drugs). The role of a multidisciplinary team for the effective
management of chronic disease is well recognized.[4] A small
Spanish survey of 11 healthcare professionals comprising medical
and nursing staff, reported a lack of understanding of the impact
of CD on daily life. However, staff were aware of this limitation
and advocated the use of a multidisciplinary team for personal-
ized CD care.[32] The need for personalized care for IBD patients
has also been highlighted by others. A large European
questionnaire-based survey of IBD patients, in cooperation with
25 national IBD associations, found that nearly two-thirds (64%)
Table 4
Multivariate analysis. Multiple logistic regression models for the IEXPAC overall experience score and for the different factors.
Overall
experience
score
Productive
Interactions
(Factor 1)
New Relational
Model
(Factor 2)
Patient
Self-management
(Factor 3)
Parameter Beta coeff. P Beta coeff. P Beta coeff. P Beta coeff. P
Sex (women vs men) 0.25 (0.25) .322 0.31 (0.30) .311 0.22 (0.28) .434 0.25 (0.31) .415
Age (per year of increment) 0.00 (0.01) .852 0.01 (0.01) .451 0.01 (0.01) .374 0.01 (0.01) .392
Educational level achieved (university or further) 0.09 (0.18) .625 0.06 (0.21) .768 0.52 (0.20) .008 0.01 (0.22) .952
Follow-up in a region different from home region (vs same region) 0.07 (0.52) .890 0.34 (0.61) .578 0.38 (0.58) .508 0.10 (0.64) .872
Being affiliated to patients’ association (vs no affiliation) 0.09 (0.41) .826 0.85 (0.50) .090 1.23 (0.48) .008 0.17 (0.51) .744
Number of specialists visited in the last year (per unit of increment) 0.10 (0.07) .151 0.09 (0.08) .291 0.11 (0.08) .151 0.10 (0.09) .260
Follow-up by the same physician (vs different) 0.96 (0.26) <.001 1.22 (0.31) <.001 0.42 (0.29) .151 1.06 (0.32) .001
Follow-up by a nurse (vs no nurse follow- up) 0.88 (0.27) .001 0.89 (0.32) .006 1.14 (0.30) <.001 0.69 (0.33) .037
Having help from others for care (vs only self-care) 0.50 (0.28) .070 0.27 (0.34) .426 0.61 (0.31) .049 0.53 (0.34) .123
Number of different medicines (per unit of increment) 0.18 (0.07) .008 0.16 (0.08) .041 0.16 (0.07) .031 0.18 (0.08) .028
Being treated with SC/IV drugs (vs no SC/IV treatment) 0.27 (0.26) .304 0.75 (0.32) .018 0.24 (0.29) .413 0.20 (0.33) .531
Beta coeff. (SD): Beta coefficient (standard deviation). Positive coefficients indicate higher IEXPAC experience scores.
IEXPAC= Instrument to Evaluate the EXperience of PAtients with Chronic diseases, IV= intravenous, SC= subcutaneous. Goodness of fit (R2): Overall experience score: 0.119; Factor 1: 0.124; Factor 2: 0.131;
Factor 3: 0.063.
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of respondents (n=4670) felt that gastroenterologists should ask
more probing questions, and over half (54%) considered that
they did not get the opportunity to tell their physician something
which was potentially important.[10] Indeed, increased patient
perception of chronic illness care was reported by IBD patients
who had received sub-specialty care, for example, a consultation
with a gastroenterologist, recent surgery or hospitalization.[33]
This emphasizes the importance of patient-healthcare profes-
sional interaction for improved patient experience of care.[3]
The limitations of this study are the same as those identified for
postal/written surveys. As this was an anonymous survey, the
patient profiles of those who did not return the survey are
unknown. No interviewer was present to moderate responses, so
respondents could not be questionned further to qualify their
answers.[34] The multivariate models explained only a small part
of the variability, but factors were identified that, if corrected,
have the potential to improve healthcare quality and patient
experience. Further research is needed in order to assess whether
IEXPAC score improvements are linked directly with improve-
ments in clinical effectiveness and HRQoL.
In conclusion, the IEXPAC scale identified areas of improve-
ment in IBD patients’ healthcare, especially those associated with
access to reliable information and services, interaction with other
patients and continuity of healthcare after hospital discharge. For
IBD patients, this analysis of data using the IEXPAC question-
naire demonstrates that a better overall patient experience was
associated with follow-up by a nurse, being seen by the same
physician, and being treated with a lower number of medicines.
These findings suggest potential actions in redirecting healthcare
resources and investment towards more patient-centered health-
care goals. The outcomes of interventions should be explored
with future research.
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